Modifying women's risk for cardiovascular disease

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 36, Issue 2, 2007, Pages 116-124

  McCauley, Kathleen M ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

Author keywords

Cardiovascular risk; Cholesterol; Healthy lifestyle; Hypertension; Women and heart disease

Indexed keywords

EID: 33947246223     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/j.1552-6909.2007.00125.x     Document Type: Review

References (47)

1. ACE Position Statement on the Insulin Resistance Syndrome. (2003). Endocrine Practice, 9, 5-21.
2. Adult Treatment Panel III. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association, 285, 2486-2497.
3. Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., et al. (2004). Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New England Journal of Medicine, 350, 1495-1504.
4. Catena, C., Novello, M., Lapenna, R., Baroselli, S., Colussi, G., Nadalini, E., et al. (2005). New risk factor for atherosclerosis in hypertension: Focus on the prothrombotic state and lipoprotein(a). Journal of Hypertension, 23, 1617-1631.
5. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine, 353, 2643-2653.
6. Dickinson, H. O., Mason, J. M., Nicolson, D. J., Campbell, F., Beyer, F., Cook, J. V., et al. (2006). Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized control trials. Journal of Hypertension, 24, 215-233.
7. Downs, J., Clearfield, M., Weis, S., Whitney, E., Shapiro, D., Beere, P., et al. (1998). Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Journal of the American Medical Association, 279, 1615-1622.
8. Fiore, M., Bailey, M., Cohen, S., Dorfman, S. F., Goldstein, M., Gritz, E., et al. (2000). Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
9. Fletcher, B., & Lamendola, C. (2004). Insulin resistance syndrome. Journal of Cardiovascular Nursing, 19, 339-345.
10. Fung, T. T., Willett, W. C., Stampfer, M. H., Manson, J. E., & Hu, F. B. (2001). Dietary patterns and the risk of coronary heart disease in women. Archives of Internal Medicine, 161, 1857-1862.
11. Grodstein, F., Manson, J. A., & Stampfer, M. (2001). Postmenopausal hormone use and secondary prevention of coronary events in the Nurses'Health Study: A prospective, observational study. Annals of Internal Medicine, 135, 1-8.
12. He, J., Whelton, P., Appel, C., Charleston, J., & Klag, M. (2000). Long-term effects of weight loss and dietary sodium restriction on incidence of hypertension. Hypertension, 35, 544-549.
13. Herrington, D., Reboussin, D., Brosnihan, B., Sharp, P., Shumaker, S., Snyder, T., et al. (2000). Effects of estrogen replacement on the progression of coronary artery atherosclerosis. New England Journal of Medicine, 343, 522-529.
14. Hsia, J., Langer, R. D., Manson, J. E., Kuller, L., Johnson, K. C., Hendrix, S. L., et al. (2006). Conjugated equine estrogens and coronary heart disease: The women's health initiative. Archives of Internal Medicine, 166, 357-365.
15. Hu, F., Bronner, L., Willett, W., Stampfer, M., Rexrode, K., Albert, C., et al. (2002). Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. Journal of the American Medical Association, 287, 1815-1821.
16. Hu, F., Stampfer, M., Solomon, C., Liu, S., Colditz, G., Speizer, F., et al. (2001). Physical activity and risk for cardiovascular events in diabetic women. Annals of Internal Medicine, 134, 96-105.
17. Hully, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women (HERS). Journal of the American Medical Association, 280, 605-613.
18. Johnson, M. L., Pietz, K., Battleman, D. S., & Beyth, R. J. (2006). Therapeutic goal attainment in patients with hypertension and dyslipidemia. Medical Care, 44, 39-46.
19. Joshipura, K., Hu, F., Manson, J. A., Stampfer, M., Rimm, E., Speizer, F., et al. (2001). The effect of fruit and vegetable intake on risk for coronary heart disease. Annals of Internal Medicine, 134, 1106-1114.
20. Kamigaki, A., Siscovick, D., Schwartz, S., Psaty, B., Edwards, K., Raghunathan, T., et al. (2001). Low density lipoprotein particle size and risk of early-onset myocardial infarction in women. American Journal of Epidemiology, 153, 939-945.
21. Kaplan, N. M., & Opie, L. H. (2005). Antihypertensive drugs. In L. H. Opie & B. J. Gersh (Eds.), Drugs for the heart (6th ed., pp. 184-217). Philadelphia: Elsevier.
22. Keating, N., Cleary, P., Rossi, A., Zaslavsky, A., & Ayanian, J. (1999). Use of hormone replacement therapy by postmenopausal women in the United States. Annals of Internal Medicine, 130, 545-553.
23. Lamarche, B., St-Pierre, A., Ruel, I., Dagenais, C., & Després, J. (2001). A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. Canadian Journal of Cardiology, 17, 859-865.
24. Lewington, S., Clark, R., Qizilbash, N., Peto, R., Collins, R., & Prospective Studies Collaboration. (2002). Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 360, 1903-1913.
25. Li, T. Y., Rana, J. S., Manson, J. E., Willett, W. C., Stampfer, M. F., Colditz, G. A., et al. (2006). Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation, 113, 499-506.
26. Manson, J., Hu, F., Rich-Edwards, J., Colditz, G., Stampfer, M., Willett, W., et al. (1999). A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. New England Journal of Medicine, 341, 650-658.
27. Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., et al. (2004). Evidence-based guidelines for cardiovascular disease prevention in women. Circulation, 109, 672-693.
28. Mosca, L., Collins, P., Herrington, D., Mendelsohn, M., Pasternak, R., Robertson, R. M., et al. (2001). Hormone replacement therapy and cardiovascular disease: A statement for health care professionals from the American Heart Association (AHA Science Advisory). Circulation, 104, 499-503.
29. Mosca, L., Manson, J., Sutherland, S., Langer, R., Manolio, T., & Barrett-Connor, E. (1997). Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association (AHA Science Advisory). Circulation, 96, 2468-2482.
30. Orth-Gomer, K., Mittleman, M., Schenck-Gustafsson, K., Wamala, S., Eriksson, M., Belkic, K., et al. (1997). Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation, 95, 329-334.
31. Rockhill, B., Willett, W., Manson, J. A., Leitzman, M., Stampfer, M., Hunter, D., et al. (2001). Physical activity and mortality: A prospective study among women. American Journal of Public Health, 91, 578-583.
32. Sacks, F., & Campos, H. (2003). Low-density lipoprotein size and cardiovascular risk: A reappraisal. Journal of Clinical Endocrinology and Metabolism, 88, 4525-4532.
33. Sacks, F., Pfeffer, M., Moye, L., Rouleau, J., Rutherford, J., Cole, T., et al. (1996). The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine, 335, 1001-1009.
34. Shai, I., Rimm, E. B., Hankinson, S. E., Cannusio, C., Curhan, G., Manson, J. E., et al. (2005). Lipoprotein(a) and coronary heart disease among women: Beyond a cholesterol carrier? European Heart Journal, 26, 1633-1639.
35. Shai, I., Rimm, E. B., Hankinson, S. E., Curhan, G., Manson, J. E., Rifai, N., et al. (2004). Multivariate assessment of lipid parameters as predictors of coronary heart disease risk among postmenopausal women: Potential implications for clinical guidelines. Circulation, 110, 2824-2830.
36. Shlipak, M., Simon, J., Vittinghoff, E., Lin, F., Barrett-Connor, E., Knopp, R., et al. (2000). Estrogen and progestin, lipoprotein(a) and the risk of recurrent coronary heart disease events after menopause. Journal of the American Medical Association, 283, 1845-1852.
37. Smith, S., Blair, S., Bonow, R., Brass, L., Cerqueira, M., Dracup, K., et al. (2001). AHA/ACC Guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Journal of the American College of Cardiology, 38, 1581-1583.
38. Stampfer, M. J., Hu, F., Manson, J. E., Rimm, E. B., & Willett, W. C. (2000). Primary prevention of coronary heart disease in women through diet and lifestyle. New England Journal of Medicine, 343, 16-22.
39. Surgeon General. (2001). Women and smoking: A report of the Surgeon General. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion.
40. Surgeon General. (2004). The health consequences of smoking: A report of the Surgeon General. Atlanta, GA: Center for Disease Control and Prevention, Office of Smoking and Health.
41. Thom, T., Haase, N., Rosamond, W., Howard, V., Rumsfeld, J., Manolio, T., et al. (2006). Heart disease and stroke statistics-2006 Update: A report from the American Heart Association statistics committee and stroke statistics committee. Circulation, 113, E85-E151.
42. Thompson, P. D., Buchner, D., Pina, I. L., Balady, G. J., Williams, M. A., Marcus, B. H., et al. (2003). Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity). Circulation, 107, 3109-3116.
43. Vasan, R. S., Beiser, A., Seshadri, S., Larson, M. G., Kannel, W. B., D'Agostino, R. B., et al. (2002). Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. Journal of the American Medical Association, 287, 1003-1010.
44. Wenger, N. (2004). You've come a long way, baby: Cardiovascular health and disease in women: Problems and prospects. Circulation, 109, 558-560.
45. Whelton, S., Chin, A., Xue, X., & He, J. (2002). Effect of aerobic exercise on blood pressure: A meta-analysis of randomized controlled trials. Annals of Internal Medicine, 136, 493-503.
46. Willett, W. C., & Stampfer, M. J. (2003). Rebuilding the food pyramid. Scientific American, 288, 64-71.
47. Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative Randomized Clinical Trial. Journal of the American Medical Association, 288, 321-333.